Please login to the form below

Not currently logged in
Email:
Password:

Verona Pharma

This page shows the latest Verona Pharma news and features for those working in and with pharma, biotech and healthcare.

Verona Pharma appoints Dr Sven Jan-Anders Karlsson as CEO

Verona Pharma appoints Dr Sven Jan-Anders Karlsson as CEO. He takes over from the UK biotech company's co-founder Michael Walker. ... Verona Pharma has appointed Dr Sven Jan-Anders Karlsson to be the respiratory-focused biotech's new CEO.

Latest news

  • The power of small

    Putting his money where his mouth is, Trevor joined Verona Pharma, a small, start-up biotech, as non-executive director of the board in September 2006. ... The Author. Michael Walker, PhD is chief executive officer and co-founder of Verona Pharma.

  • Malcolm's Market Eye: 6 to 12 October 2007

    Verona Pharma may have secured go ahead for chronic respiratory drug. ... Verona Pharma, the life sciences company, is focusing on therapeutic drugs with which to treat asthma, hay- fever and other chronic respiratory ailments.

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Dr Desiree Luthman joins Verona Pharma Dr Desiree Luthman joins Verona Pharma

    Dr Desiree Luthman joins Verona Pharma. She takes up its vice president position. ... Jan-Anders Karlsson, chief executive officer of Verona Pharma, said: “We welcome Desiree to our growing pharma team.

  • Verona Pharma strengthens senior management team Verona Pharma strengthens senior management team

    Verona Pharma has appointed Richard Hennings in a role that will see him oversee the firm’s marketing access strategy and increase its commercial focus. ... Jan-Anders Karlsson, CEO of Verona Pharma, said: “We are delighted to welcome Richard to the

  • Mereo BioPharma’s Richard Bungay to step down Mereo BioPharma’s Richard Bungay to step down

    He has previously held the chief financial title at Glide Pharmaceutical Technologies, Chroma Therapeutics and Verona Pharma, remaining as a non-executive board director at both Glide and Chroma.

  • Vikas Sinha joins Verona as non-executive director Vikas Sinha joins Verona as non-executive director

    UK drug development company Verona Pharma has appointed Vikas Sinha as a non-executive director. ... Dr David Ebsworth, chairman of Verona Pharma, said: “ Vikas' impressive financial background, including his US expertise, makes him a very welcome

  • Verona names David Ebsworth as non-executive chairman Verona names David Ebsworth as non-executive chairman

    Verona Pharma has appointed Dr David Ebsworth as its non-executive chairman of the board of directors. ... David' significant expertise in the pharma industry strongly supports Verona Pharma's focus on high value commercial opportunities and future growth

More from appointments
Approximately 4 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics